Teleflex (NYSE:TFX) Updates FY 2026 Earnings Guidance

Teleflex (NYSE:TFX) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 6.250-6.550 for the period, compared to the consensus earnings per share estimate of 6.730. The company issued revenue guidance of $2.3 billion-$2.3 billion, compared to the consensus revenue estimate of $2.3 billion.

Analysts Set New Price Targets

Several research firms have commented on TFX. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research note on Friday, March 27th. Needham & Company LLC increased their price target on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price on the stock in a research report on Monday, April 13th. Zacks Research upgraded Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Finally, Mizuho set a $140.00 target price on Teleflex in a research report on Friday. Three research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $142.86.

Teleflex Trading Up 1.1%

NYSE TFX traded up $1.49 during trading hours on Friday, hitting $133.17. 947,217 shares of the company’s stock were exchanged, compared to its average volume of 1,030,809. The business’s 50 day moving average is $119.44 and its 200-day moving average is $116.73. Teleflex has a 12-month low of $100.18 and a 12-month high of $139.67. The firm has a market capitalization of $5.89 billion, a P/E ratio of -5.84, a price-to-earnings-growth ratio of 0.95 and a beta of 0.82. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.01 and a current ratio of 2.55.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The company had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company’s quarterly revenue was up 32.3% compared to the same quarter last year. During the same period last year, the business posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, analysts anticipate that Teleflex will post 6.75 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date was Friday, March 6th. Teleflex’s dividend payout ratio (DPR) is -6.62%.

More Teleflex News

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Teleflex beat Q1 estimates, reporting adjusted EPS of $1.39 versus $1.21 expected and revenue of $548.3 million versus $536.9 million expected, which signals solid execution in the quarter. Article Title
• Positive Sentiment: The company maintained its full-year 2026 outlook and announced plans for a buyback, which can support investor confidence and share price performance. Article Title
• Positive Sentiment: Wells Fargo raised its price target on TFX from $130 to $138, implying modest upside from current levels and suggesting improved analyst sentiment. Article Title
• Neutral Sentiment: Management’s earnings call commentary was described as balanced, with growth offset by margin strain, indicating the business is still navigating profitability pressure even after the earnings beat. Article Title
• Negative Sentiment: Teleflex’s updated FY2026 EPS guidance of $6.25 to $6.55 came in below the market’s expectation of about $6.73, which could limit enthusiasm despite the quarterly beat. Article Title

Hedge Funds Weigh In On Teleflex

A number of large investors have recently modified their holdings of the company. UMB Bank n.a. grew its stake in shares of Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after buying an additional 113 shares in the last quarter. Kestra Advisory Services LLC acquired a new stake in shares of Teleflex in the fourth quarter valued at about $45,000. Danske Bank A S acquired a new stake in shares of Teleflex in the third quarter valued at about $54,000. State of Wyoming acquired a new stake in shares of Teleflex in the second quarter valued at about $111,000. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Teleflex by 108.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock valued at $119,000 after buying an additional 521 shares in the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.